ATE295363T1 - Beta-laktame zur herstellung von taxanen mit furyl oder thienyl substituierter seitenkette - Google Patents

Beta-laktame zur herstellung von taxanen mit furyl oder thienyl substituierter seitenkette

Info

Publication number
ATE295363T1
ATE295363T1 AT02009840T AT02009840T ATE295363T1 AT E295363 T1 ATE295363 T1 AT E295363T1 AT 02009840 T AT02009840 T AT 02009840T AT 02009840 T AT02009840 T AT 02009840T AT E295363 T1 ATE295363 T1 AT E295363T1
Authority
AT
Austria
Prior art keywords
furyl
side chain
lactames
taxanes
beta
Prior art date
Application number
AT02009840T
Other languages
English (en)
Inventor
Robert A Holton
Hossain Nadizadeh
Ronald J Biediger
Kasthuri Rengan
Yukio Suzuki
Ki-Byung Chai
Hamid Idmoumaz
Original Assignee
Univ Florida State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State filed Critical Univ Florida State
Application granted granted Critical
Publication of ATE295363T1 publication Critical patent/ATE295363T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/87Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/60Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
    • C07C2603/62Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing three- or four-membered rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT02009840T 1993-03-22 1994-03-21 Beta-laktame zur herstellung von taxanen mit furyl oder thienyl substituierter seitenkette ATE295363T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3485293A 1993-03-22 1993-03-22
US9471793A 1993-07-20 1993-07-20

Publications (1)

Publication Number Publication Date
ATE295363T1 true ATE295363T1 (de) 2005-05-15

Family

ID=26711460

Family Applications (5)

Application Number Title Priority Date Filing Date
AT02019282T ATE295164T1 (de) 1993-03-22 1994-03-21 Taxane mit furyl oder thienyl enthaltender substituierter seitenkette
AT02009840T ATE295363T1 (de) 1993-03-22 1994-03-21 Beta-laktame zur herstellung von taxanen mit furyl oder thienyl substituierter seitenkette
AT02009839T ATE284689T1 (de) 1993-03-22 1994-03-21 Pharmazeutische zusammenstellungen enthaltende eine furyl oder thienyl substituierte seitenkette
AT94911675T ATE232871T1 (de) 1993-03-22 1994-03-21 Taxane mit furyl-oder thienyl substituierten seitenketten
AT94910982T ATE254914T1 (de) 1993-03-22 1994-03-21 Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02019282T ATE295164T1 (de) 1993-03-22 1994-03-21 Taxane mit furyl oder thienyl enthaltender substituierter seitenkette

Family Applications After (3)

Application Number Title Priority Date Filing Date
AT02009839T ATE284689T1 (de) 1993-03-22 1994-03-21 Pharmazeutische zusammenstellungen enthaltende eine furyl oder thienyl substituierte seitenkette
AT94911675T ATE232871T1 (de) 1993-03-22 1994-03-21 Taxane mit furyl-oder thienyl substituierten seitenketten
AT94910982T ATE254914T1 (de) 1993-03-22 1994-03-21 Taxane ohne die c-9 oxo gruppe und diese enthaltende pharmazeutische präparate

Country Status (12)

Country Link
EP (6) EP1227093B1 (de)
JP (2) JPH08508469A (de)
AT (5) ATE295164T1 (de)
AU (3) AU6367994A (de)
CA (2) CA2158454C (de)
DE (5) DE69434190T2 (de)
DK (5) DK1260223T3 (de)
ES (5) ES2193155T3 (de)
IL (4) IL109050A0 (de)
PT (5) PT1228759E (de)
SG (3) SG68049A1 (de)
WO (2) WO1994021250A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712289B1 (fr) * 1993-11-08 1996-01-05 Rhone Poulenc Rorer Sa Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5677470A (en) * 1994-06-28 1997-10-14 Tanabe Seiyaku Co., Ltd. Baccatin derivatives and processes for preparing the same
AU4133096A (en) * 1994-10-28 1996-05-23 Research Foundation Of The State University Of New York, The Taxoid derivatives, their preparation and their use as antitumor agents
US6500858B2 (en) 1994-10-28 2002-12-31 The Research Foundation Of The State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US6458976B1 (en) 1994-10-28 2002-10-01 The Research Foundation Of State University Of New York Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
CA2162759A1 (en) * 1994-11-17 1996-05-18 Kenji Tsujihara Baccatin derivatives and processes for preparing the same
JP2964475B2 (ja) 1994-11-17 1999-10-18 田辺製薬株式会社 バッカチン誘導体及びその製法
PT826688E (pt) 1995-04-28 2002-02-28 Daiichi Seiyaku Co Composto pentaciclico
JP2001524067A (ja) * 1995-09-13 2001-11-27 フロリダ・ステイト・ユニバーシティ 放射線感作性タキサン類およびその医薬製剤
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2746797B1 (fr) * 1996-03-27 1998-06-19 Centre Nat Rech Scient Nouveaux derives du 10-acetyldocetaxel et leur procede de preparation
EP0927175A4 (de) * 1996-05-06 2002-05-22 Univ Florida State 1-deoxybaccatin iii, 1-deoxytaxol und 1-deoxytaxol-analoge und verfahren zu ihrer herstellung
WO1998017656A1 (en) * 1996-10-24 1998-04-30 Institute Armand-Frappier A family of canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof
DE60136430D1 (de) * 2000-02-02 2008-12-18 Univ Florida State Res Found Heterosubstituierte c7-taxanacetate als antitumormittel
CA2368274C (en) * 2000-02-02 2009-10-13 Florida State University Research Foundation, Inc. C10 ester substituted taxanes as antitumor agents
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
EP1810968A3 (de) * 2003-09-25 2007-08-08 Tapestry Pharmaceuticals, Inc. 9, 10-a, a-OH-Taxan-Analoge und Herstellungsverfahren dafür
PT1664033E (pt) * 2003-09-25 2008-01-17 Tapestry Pharmaceuticals Inc Análogos de 9,1o-a,a-oh-taxanos e processos para sua produção
EP1737444A4 (de) * 2004-03-05 2008-05-21 Univ Florida State Res Found C7-lactyloxa-substituierte taxane
AU2006258079A1 (en) * 2005-06-10 2006-12-21 Florida State University Research Foundation, Inc. Resolution of enantiomeric mixtures of beta-lactams
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6075458A (ja) * 1983-06-17 1985-04-27 Osaka Soda Co Ltd 3,4−ジフエニル−1−(4−置換)アリ−ルメチルアゼチジン−2−オンの製法
US4751299A (en) * 1983-11-18 1988-06-14 Takeda Chemical Industries, Ltd. Optically active β-lactams and method of their production
JPS61243079A (ja) * 1985-04-01 1986-10-29 Mect Corp 1−(アルコキシカルボニルアルキル)−4−(2−フリル)−3−置換−2−アゼチジノン及びその製造方法
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5006650A (en) * 1987-02-11 1991-04-09 The Upjohn Company Novel N-1 substituted beta-lactams as antibiotics
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
AU637109B2 (en) * 1989-06-22 1993-05-20 Rijksuniversiteit Utrecht Improved synthesis of beta-lactams using a metal compound
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
HU225474B1 (en) * 1991-09-23 2006-12-28 Univ Florida State New 10-desacetoxytaxol derivatives, pharmaceutical derivatives containing them and procedure for preparing them
EP0884314B1 (de) * 1991-09-23 2004-01-21 Florida State University Metallalkoxide
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5284864A (en) * 1991-09-23 1994-02-08 Florida State University Butenyl substituted taxanes and pharmaceutical compositions containing them
US5283253A (en) * 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
FR2688518B1 (fr) * 1992-03-13 1994-05-06 Rhone Poulenc Rorer Sa Procede de preparation de derives du taxane.
JPH07505887A (ja) * 1992-04-17 1995-06-29 アボツト・ラボラトリーズ タキソール誘導体
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.

Also Published As

Publication number Publication date
PT1260223E (pt) 2005-09-30
EP0689436A1 (de) 1996-01-03
IL180090A0 (en) 2007-05-15
DE69434190T2 (de) 2005-05-25
DE69433355T2 (de) 2004-05-27
IL109052A0 (en) 1994-06-24
DE69434374D1 (de) 2005-06-16
PT1228759E (pt) 2005-04-29
CA2158862C (en) 2006-10-10
PT690867E (pt) 2003-06-30
DK1260223T3 (da) 2005-09-05
SG89298A1 (en) 2002-06-18
AU6413894A (en) 1994-10-11
DE69433355D1 (de) 2004-01-08
EP1227093B1 (de) 2005-05-11
EP0689436B1 (de) 2003-11-26
EP0690867B1 (de) 2003-02-19
WO1994021651A1 (en) 1994-09-29
ES2193155T3 (es) 2003-11-01
SG68049A1 (en) 2001-08-21
EP0690867A4 (de) 1996-03-20
EP1398028A3 (de) 2004-03-24
PT1227093E (pt) 2005-09-30
AU7863698A (en) 1998-10-01
EP1228759A2 (de) 2002-08-07
EP1260223B1 (de) 2005-05-11
EP0690867A1 (de) 1996-01-10
DK0690867T3 (da) 2003-06-10
DE69434374T2 (de) 2005-11-24
AU691804B2 (en) 1998-05-28
ES2211879T3 (es) 2004-07-16
DK1227093T3 (da) 2005-08-29
ATE232871T1 (de) 2003-03-15
ATE284689T1 (de) 2005-01-15
ATE254914T1 (de) 2003-12-15
CA2158862A1 (en) 1994-09-29
DE69432141T2 (de) 2003-07-31
AU714180B2 (en) 1999-12-23
DK1228759T3 (da) 2005-04-18
DK0689436T3 (da) 2004-03-29
EP1228759B1 (de) 2004-12-15
PT689436E (pt) 2004-04-30
EP1228759A3 (de) 2002-09-25
WO1994021250A1 (en) 1994-09-29
CA2158454C (en) 2006-05-23
ES2241923T3 (es) 2005-11-01
IL190945A0 (en) 2009-02-11
DE69434190D1 (de) 2005-01-20
AU6367994A (en) 1994-10-11
CA2158454A1 (en) 1994-09-29
EP0689436A4 (de) 1996-02-07
IL109052A (en) 2009-07-20
JPH08508469A (ja) 1996-09-10
ES2242807T3 (es) 2005-11-16
ATE295164T1 (de) 2005-05-15
DE69432141D1 (de) 2003-03-27
DE69434373T2 (de) 2006-03-09
JPH08508255A (ja) 1996-09-03
DE69434373D1 (de) 2005-06-16
EP1398028A2 (de) 2004-03-17
IL109050A0 (en) 1994-06-24
EP1227093A2 (de) 2002-07-31
ES2232694T3 (es) 2005-06-01
SG73401A1 (en) 2000-06-20
EP1260223A1 (de) 2002-11-27
EP1227093A3 (de) 2002-08-07

Similar Documents

Publication Publication Date Title
ATE295363T1 (de) Beta-laktame zur herstellung von taxanen mit furyl oder thienyl substituierter seitenkette
DE69507702D1 (de) Semisynthetisch taxal derivate mit antitumor wirkung
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
AR020848A1 (es) Metodos y composiciones para la prevencion y el tratamiento de anemia
MX9304360A (es) Derivados de rapamicina y composiciones farmaceuticas de los mismos.
MX9304361A (es) Derivados de rapamicina.
ATE442129T1 (de) Camptothecin-carboxylat-formulierungen
ATE289810T1 (de) Ecteinascidinderivate
DE69431476D1 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
EA200300272A1 (ru) Новые производные хиназолина, способ их получения и фармацевтические композиции, содержащие их
DE60206940D1 (de) Pektin und ascorbinsäure enthaltende zusammensetzungen
IT1302289B1 (it) Composizioni farmaceutiche ad attivita' antineoplastica
ES2181722T3 (es) Marcfortinas sustituidas en la posicion 14 y derivados utiles como agentes antiparasitarios.
ECSP972024A (es) Mezclas de dos componentes fungicidas basadas en metalaxilo
TNSN05008A1 (en) Heterocyclically substituted benzoylureas, method for their production and their use as medicaments.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1227093

Country of ref document: EP

REN Ceased due to non-payment of the annual fee